1225 related articles for article (PubMed ID: 12829898)
21. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
Bergquist A; Glaumann H; Persson B; Broomé U
Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
[TBL] [Abstract][Full Text] [Related]
22. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
Wiesner RH
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
24. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
[TBL] [Abstract][Full Text] [Related]
25. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
[TBL] [Abstract][Full Text] [Related]
28. Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: impact on posttransplant outcome.
Keaveny AP; Gordon FD; Goldar-Najafi A; Lewis WD; Pomfret EA; Pomposelli JJ; Jenkins RL; Khettry U
Liver Transpl; 2004 Jan; 10(1):115-22. PubMed ID: 14755787
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe?
Lian L; Menon KV; Shen B; Remzi F; Kiran RP
Dis Colon Rectum; 2012 Jan; 55(1):79-84. PubMed ID: 22156871
[TBL] [Abstract][Full Text] [Related]
30. Carcinogenesis in inflammatory bowel disease.
Herszenyi L; Miheller P; Tulassay Z
Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
[TBL] [Abstract][Full Text] [Related]
31. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.
Campsen J; Zimmerman MA; Trotter JF; Wachs M; Bak T; Steinberg T; Kam I
Liver Transpl; 2008 Feb; 14(2):181-5. PubMed ID: 18236392
[TBL] [Abstract][Full Text] [Related]
32. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
Tischendorf JJ; Meier PN; Strassburg CP; Klempnauer J; Hecker H; Manns MP; Krüger M
Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210
[TBL] [Abstract][Full Text] [Related]
33. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
35. Chemoprevention for colon cancer: new opportunities, fact or fiction?
Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
[TBL] [Abstract][Full Text] [Related]
36. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
Cholongitas E; Papatheodoridis GV; Zappoli P; Giannakopoulos A; Patch D; Marelli L; Shusang V; Kalambokis G; Shirling G; Rolando N; Burroughs AK
Liver Transpl; 2007 Apr; 13(4):552-7. PubMed ID: 17394153
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer after orthotopic liver transplantation.
Silva MA; Jambulingam PS; Mirza DF
Crit Rev Oncol Hematol; 2005 Oct; 56(1):147-53. PubMed ID: 16140543
[TBL] [Abstract][Full Text] [Related]
38. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR; Lashner BA; Hanauer SB
Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
[TBL] [Abstract][Full Text] [Related]
39. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
[TBL] [Abstract][Full Text] [Related]
40. Dysplasia and cancer in inflammatory bowel disease.
Basseri RJ; Basseri B; Papadakis KA
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
